RARA CRAFT DATABASE for FDA Medical Devices
510(k)K262571

FDA DEVICE FACTS

EnCor EnCompass™ Breast Biopsy and Tissue Removal System

Bard Peripheral Vascular, Inc.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEAugust 14, 2026PRODUCT CODEKNW

Indications for use

The EnCor EnCompass ™ Breast Biopsy and Tissue Removal System is indicated to acquire breast tissue for histologic examination with partial or complete removal of the abnormality. Q BD Special 510(k): Software Modification EnCor EnCompass™ Breast Biopsy and Tissue Removal System Bard Peripheral Vascular, Inc. Technological Comparison to Predicate Device: The EnCor EnCompass ™ Breast Biopsy and Tissue Removal System has the following similarities to the predicate device (K252681, cleared on December 12th, 2025).

• Same intended use

• Same indications for use

• Same target patient population

• Same principle of operation

• Same fundamental scientific technology

• Same operating principle (mode of action)

• Same sterility level and method of sterilization

• Same packaging configuration

• Same materials

• Same wireless technology The subject device and the predicate devices are different in the following manner:

• Software modifications

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: September 30, 2026